msg treatment resulted in a significant reduction in medial basal hypothalamic ( mbh ) da levels , no change in its norepinephrine ( ne ) and epinephrine ( e ) concentrations , and a marked increase in circulating prolactin ( prl ) .
C0028351
norepinephrine
C0014563
epinephrine